On Tuesday, Bank of the Ozarks, Inc. (NASDAQ:OZRK)’s shares surged 3.53% to $38.96, hitting its highest level, after OZRK declared that net revenue for the first quarter of 2015 was $39.9 million, a 57.8% raise from $25.3 million for the first quarter of 2014. Diluted earnings per ordinary share for the first quarter of 2015 were $0.47, a 38.2% raise from $0.34 for the first quarter of 2014.
The Company’s results during the quarter just ended comprised of $2.3 million of tax-exempt revenue from bank owned life insurance death benefits, $2.5 million in net gains on sales of investment securities, $2.5 million in prepayment penalties from prepaying Federal Home Loan Bank advances, attainment-related and systems conversion expenses of about $1.3 million and software and contract termination charges of about $0.7 million. Net of applicable revenue taxes, these items, in the aggregate, added about $0.01 to the Company’s diluted earnings per ordinary share in the quarter just ended.
On February 10, 2015, the Company accomplished its formerly declared attainment of Intervest Bancshares Corporation with operations in New York and Florida. During 2014 the Company accomplished its attainments of Texas-based Bancshares, Inc. (“Bancshares”) in March and Arkansas-based Summit Bancorp, Inc. in May.
On June 23, 2014, the Company accomplished a 2-for-1 stock split, in the form of a stock dividend, by issuing one share of ordinary stock for each share of such stock outstanding on June 13, 2014. All share and per share information in this release has been adjusted to give effect to this stock split.
Bank of the Ozarks, Inc. operates as the bank holding company for Bank of the Ozarks that provides a range of retail and commercial banking services. The company accepts various deposits products, such as checking, savings, money market, time deposit, and individual retirement accounts.
Nektar Therapeutics (NASDAQ:NKTR)’s shares gained 3.52% to $11.77, during the last trading session on Tuesday, as NKTR declared that the company will be webcasting its corporate presentation at the 14th Annual Needham Healthcare Conference to be held at the Westin Grand Central Hotel in New York, on Wednesday, April 15, 2015 at 8:00 a.m. Eastern Time.
Nektar Therapeutics, a biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline comprises drug candidates in therapeutic areas comprising oncology, pain, anti-infectives, and immunology.
At the end of Tuesday’s trade, ONEOK Inc. (NYSE:OKE)’s shares gained 3.25% to $49.20, as OKE and ONEOK Partners, L.P. (OKS) will release their first-quarter 2015 earnings after the market closes on May 5, 2015.
ONEOK’s and ONEOK Partners’ executive administration will take part in a joint conference call the following day at 11 a.m. Eastern Daylight Time (10 a.m. Central Daylight Time) on May 6, 2015. The call also will be carried live on ONEOK’s and ONEOK Partners’ websites.
ONEOK, Inc. engages in the gathering, processing, storage, and transportation of natural gas in the United States. It operates in Natural Gas Gathering and Processing, Natural Gas Liquids, and Natural Gas Pipelines segments.
Finally, Chesapeake Energy Corporation (NYSE:CHK), ended its Tuesday’s trading session with 3.25% gain, and closed at $15.25, as CHK has planned to release its 2015 first quarter financial and operational results before market open on Wednesday, May 6, 2015. A conference call to talk about the results has been planned for the same day at 9:00 am EDT. The telephone number to access the conference call is 913-312-1393 or toll-free 888-797-2983. The passcode for the call is 3887326. We encourage those who would like to take part in the call to place calls between 8:50 and 9:00 am EDT.
Chesapeake Energy Corporation engages in the attainment, exploration, and development of properties for the production of oil, natural gas and natural gas liquids (NGL) from underground reservoirs in the United States. It holds interests in natural gas resource plays, counting the Haynesville/Bossier Shales in northwestern Louisiana and East Texas; the Marcellus Shale in the northern Appalachian Basin of West Virginia and Pennsylvania; and the Barnett Shale in the Fort Worth Basin of north-central Texas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
